Clinical Trials on Leucémie, myéloïde

Total 5 results

German CLL Study Group
AbbVie; Hoffmann-La Roche

Active, not recruiting

Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)

Chronic Lymphocytic Leucemia

Germany
Hadassah Medical Organization

Unknown

F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML) (AML F18-FLT)

Acute Myeloid Leucemia

Israel
German CLL Study Group
Gilead Sciences; Hoffmann-La Roche

Completed

Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG)

Chronic Lymphocytic Leucemia

Germany
German CLL Study Group
Hoffmann-La Roche; Janssen-Cilag Ltd.

Completed

Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients

Chronic Lymphocytic Leucemia

Germany
Munich Municipal Hospital
German CLL Study Group

Unknown

CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients

Chronic Lymphocytic Leucemia

Germany

3

Subscribe